The femtech sector's evolution presents opportunities for tech, healthcare, and life sciences companies that are both vast and largely...

High-volume patent monetization entities have long focused on targets in the information technology and software sectors. But that trend...

With the U.S. industries looking to focus shifting back manufacturing onshore, thinking about holistic IP strategies to protect such...

A major Federal Circuit ruling just sent a clear message to AI-driven healthtech companies: AI alone won’t get you a patent. In AliveCor,...

The U.S. Patent and Trademark Office (USPTO) faces unique challenges amid discussions on altering telework policies. With 96% of its...

Assessing Risks and Impacts of AI (ARIA) is a research program by the National Institute of Standards and Technology (NIST) aimed at...

The U.S. Patent and Trademark Office (USPTO) has implemented three new rules impacting practice before the Patent Trial and Appeal Board...

U.S. Patent and Trademark Office Director Kathi Vidal announced her departure from the agency to return to the private sector, a move...

The U.S. Patent and Trademark Office director, Kathi Vidal, released a final rule on Director Review effective October 31, which expands...

The United States Patent and Trademark Office (USPTO) has announced new rules governing amendment practice in trial proceedings under the...

In patent litigation, expert witnesses play a crucial role in providing specialized knowledge to the court. In a recent case where Osseo...

The recent case involving United Therapeutics' patent on Tyvaso and Liquidia's Yutrepia sheds light on the complexities of patent law....